Lipoxygenase Inhibitors

All categories
DBCAT000422Therapeutic category

Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. A DrugBank category of 10 drugs. 3 of them are approved.

Also known as
12 Lipoxygenase Inhibitors · 12-Lipoxygenase Inhibitors · 12-Lipoxygenase Inhibitors, Arachidonate · 15 Lipoxygenase Inhibitors · 15-Lipoxygenase Inhibitors
Drugs

What you can answer from here — as of September 15, 2022

10DrugsEach linked to its full drug card
Listed above
11Drug targetsEvery drug–target pair in the class, with bond type
Sign in
25Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Lipoxygenase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In